NEW DEVELOPMENTS IN NEUROIMMUNOLOGY
Insights from the differences in clinical profiles of neuroimmune disorders between patients in Japan and those in Western countries
Masahiro Mori,
Corresponding Author
Masahiro Mori
Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan
Correspondence
Masahiro Mori, Department of Neurology, Graduate School of Medicine, Chiba University, 1–8–1, Inohana, Chuo–ku, Chiba 260–8670, Japan.
Email: [email protected]
Search for more papers by this author
Masahiro Mori,
Corresponding Author
Masahiro Mori
Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan
Correspondence
Masahiro Mori, Department of Neurology, Graduate School of Medicine, Chiba University, 1–8–1, Inohana, Chuo–ku, Chiba 260–8670, Japan.
Email: [email protected]
Search for more papers by this author
First published: 12 March 2021
No abstract is available for this article.
DISCLOSURE
Conflict of interest: The author declares no conflict of interest.
REFERENCES
- 1Kuroiwa Y, Igata A, Itahara K, Koshijima S, Tsubaki T, Toyokura Y, et al. Nationwide survey of multiple sclerosis in Japan. Clinical analysis of 1,084 cases. Neurology. 1975; 25: 845–51.
- 2Shibasaki H, McDonald WI, Kuroiwa Y. Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients. J Neurol Sci. 1981; 49: 253–71.
- 3Nakamura Y, Gaetano L, Matsushita T, Anna A, Sprenger T, Radue E-W, et al. A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression. J Neuroinflammation. 2018; 15: 255.
- 4Kitley J, Leite MI, Nakashima I, Waters P, McNeillis B, Brown R, et al. Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain. 2012; 135: 1834–49.
- 5Liu J, Mori M, Zimmermann H, Brandt A, Havla J, Tanaka S, et al. Anti-MOG antibody-associated disorders: differences in clinical profiles and prognosis in Japan and Germany. J Neurol Neurosurg Psychiatry. 2021; 92(4): 377–83.
